Centessa Pharmaceuticals Announces Dosing of First Subject in Registrational PRESent-3 Study Evaluating SerpinPC for the Treatment of Hemophilia B with Inhibitors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) has earned an average rating of “Moderate Buy” from the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have issued a buy recommendation on […]
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Free Report) – Leerink Partnrs decreased their Q3 2023 EPS estimates for shares of Centessa Pharmaceuticals in a research note issued to investors on Tuesday, August 15th. Leerink Partnrs analyst D. Risinger now expects that the company will post earnings per share of ($0.45) for the quarter, down from their […]
Centessa Pharmaceuticals plc to Post Q3 2023 Earnings of ($0 45) Per Share, Leerink Partnrs Forecasts (NASDAQ:CNTA) kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.